Altice USA (NYSE: ATUS) insider Dexter Goei files Rule 144 to sell shares

Rhea-AI Filing Summary

Altice USA insider Dexter Goei filed a Rule 144 notice to sell up to 109,505 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $208,683.68. The filing states that 285,388,630 shares of common stock were outstanding, providing context for the planned sale. The shares to be sold were acquired on 06/08/2018 through a Profit Interest Program from the issuer as compensation.

Over the past three months, Dexter Goei has already sold additional Altice USA common shares, including 695,195 shares on 11/26/2025 for $1,324,068.40, 184,898 shares on 12/01/2025 for $355,318.49, 32,228 shares on 12/02/2025 for $61,233.20, and 114,410 shares on 12/03/2025 for $217,401.88. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about Altice USA.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	109505	208683.68	285388630	12/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/08/2018	Profit Interest Program	Issuer			109505	06/08/2018	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/03/2025	114410	217401.88
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/02/2025	32228	61233.20
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/01/2025	184898	355318.49
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	11/26/2025	695195	1324068.40

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Altice USA (ATUS) insider Dexter Goei file in this Form 144?

Dexter Goei filed a Rule 144 notice indicating his intention to sell up to 109,505 shares of Altice USA common stock through Morgan Stanley Smith Barney LLC.

How many Altice USA (ATUS) shares are planned for sale and what is their market value?

The notice covers up to 109,505 common shares of Altice USA with an aggregate market value of $208,683.68 as stated in the filing.

How many Altice USA (ATUS) shares were outstanding at the time referenced in the Form 144?

The filing reports that 285,388,630 shares of Altice USA common stock were outstanding, giving context to the size of the planned sale.

How did Dexter Goei acquire the Altice USA (ATUS) shares he plans to sell?

The shares to be sold were acquired on 06/08/2018 through a Profit Interest Program from the issuer as compensation, in an amount of 109,505 shares.

What Altice USA (ATUS) share sales has Dexter Goei made in the past three months?

In the past three months, Dexter Goei sold Altice USA common stock in several transactions, including 695,195 shares on 11/26/2025 for $1,324,068.40 and other smaller sales on 12/01/2025, 12/02/2025, and 12/03/2025 with disclosed gross proceeds.

What representation does Dexter Goei make about Altice USA (ATUS) in the Form 144?

By signing the notice, Dexter Goei represents that he does not know any material adverse information about the current or prospective operations of Altice USA that has not been publicly disclosed.